Menu Back toSession 9 Regulatory Sprint: Can We Develop an Agile Regulatory Decision Matrix for Digital Measurement?

Digital Technology in Clinical Trials

This event is now offered in a new entirely virtual format.

Session 9 Regulatory Sprint: Can We Develop an Agile Regulatory Decision Matrix for Digital Measurement?

Session Chair(s)

Lauren Oliva, PharmD, RPh

Lauren Oliva, PharmD, RPh

  • Director, Global Regulatory Policy & Digital Health Policy Lead
  • Biogen, United States
Megan Doyle, JD, MPH

Megan Doyle, JD, MPH

  • Global Policy Lead, Digital Health, Diagnostics, Oncology, & Combination Product
  • Amgen, United States
Anindita Saha

Anindita Saha

  • Assistant Director, Digital Health Center of Excellence, CDRH
  • FDA, United States
This interactive panel session will explore a fictional case study of a digital health technology (DHT) used as a measurement tool in a drug clinical trial. An expert panel will engage in a dialogue, including audience polls and Q&A, about regulatory considerations for selection of the most appropriate endpoint, how to measure the endpoint, and verification and validation as it applies to the hypothetical case study.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Explore evidence criteria to be addressed for digital health technologies (DHTs) in clinical trials through a case example
  • Evaluate regulatory questions based on drug program goals and DHT medical device status and intended use

Speaker(s)

Anindita Saha

Speaker

Anindita Saha

  • Assistant Director, Digital Health Center of Excellence, CDRH
  • FDA, United States
Jeffrey Siegel, MD

Speaker

Jeffrey Siegel, MD

  • Director, Office of Drug Evaluation Sciences, Office of New Drugs, CDER
  • FDA, United States
Elizabeth Kunkoski, MS

Speaker

Elizabeth Kunkoski, MS

  • Health Science Policy Analyst, OMP, CDER
  • FDA, United States
Matthew Diamond, MD, PhD

Speaker

Matthew Diamond, MD, PhD

  • Chief Medical Officer, Digital Health Center of Excellence, CDRH
  • FDA, United States
Samantha Roberts, PhD

Speaker

Samantha Roberts, PhD

  • Group Director, US Regulatory Policy
  • Genentech, A Member of the Roche Group, United States
Simon Bennett, MSc

Speaker

Simon Bennett, MSc

  • Director, EU Regulatory Policy
  • Biogen, United Kingdom

Contact us

Registration Questions?

Send Email
1.888.257.6457

Preconference Short Courses

Short Course 1: Approaches for Developing Novel Digital Endpoints for Medical Product Development

Additional Information

Sign up to be notified when registration opens for the DIA 2022 Events

Digital Technology in Clinical Trials Resource Kit